Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-07 · accession 0001209191-21-045989 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-08 | 2021-07-07 | PMVP | Alland Leila | Chief Medical Off | S - Sale+OE | $32.30 | -4,000 | 2,049 | -66% | -$129.2K |
| D | 2021-07-08 | 2021-07-07 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $3.90 | +4,000 | 4,000 | New | +$15.6K |
| D | 2021-07-08 | 2021-07-07 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $0.00 | -4,000 | 361.9K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-07 | S | D | 2,049 | $32.66 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.455 to $32.835, inclusive. |
| 2 | Common | Common Stock | 2021-07-07 | S | D | 1,951 | $31.93 | 2,049 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.455 to $32.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. |
| 3 | Common | Common Stock | 2021-07-07 | M | A | 4,000 | $3.90 | 4,000 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2021-07-07 | M | D | 4,000 | $0.00 | 361,850 | D | $3.90 · — to 2030-02-04 | 4,000 Common Stock | (F4) One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. |